-
Founded in:
2003-12-16 -
Country:
China -
Address:
No. 209, Hongqi Road, Linyi City -
Tax NO.:
91371300756399007K -
Registered Funds:
115 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Rosuvastatin calcium |
Rosuvastatin is a selective, competitive HMG-CoA reductase inhibitor that increases the number of liver LDL receptors on the cell surface, enhances the uptake and catabolism of LDL, and inhibits liver VLDL synthesis, thereby reducing the total number of VLDL and LDL particles. For patients with multiple hypercholesterolemia and dyslipidemia, rosuvastatin can reduce total cholesterol, LDL-C, ApoB, non-HDL-C levels, while reducing TG and increasing HDL-C levels.
More
Rosuvastatin is a selective, competitive HMG-CoA reductase inhibitor that increases the number of liver LDL receptors on the cell surface, enhances the uptake and catabolism of LDL, and inhibits liver VLDL synthesis, thereby reducing the total number of VLDL and LDL particles. For patients with multiple hypercholesterolemia and dyslipidemia, rosuvastatin can reduce total cholesterol, LDL-C, ApoB, non-HDL-C levels, while reducing TG and increasing HDL-C levels. |
147098-20-2 | 121 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Rosuvastatin calcium |
Rosuvastatin is a selective, competitive HMG-CoA reductase inhibitor that increases the number of liver LDL receptors on the cell surface, enhances the uptake and catabolism of LDL, and inhibits liver VLDL synthesis, thereby reducing the total number of VLDL and LDL particles. For patients with multiple hypercholesterolemia and mixed dyslipidemia, rosuvastatin can reduce total cholesterol, LDL-C, ApoB, non-HDL-C levels, while reducing TG and increasing HDL-C levels.
More
Rosuvastatin is a selective, competitive HMG-CoA reductase inhibitor that increases the number of liver LDL receptors on the cell surface, enhances the uptake and catabolism of LDL, and inhibits liver VLDL synthesis, thereby reducing the total number of VLDL and LDL particles. For patients with multiple hypercholesterolemia and mixed dyslipidemia, rosuvastatin can reduce total cholesterol, LDL-C, ApoB, non-HDL-C levels, while reducing TG and increasing HDL-C levels. |
147098-20-2 | 121 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Policresulen |
Extract from the above information
More
Extract from the above information |
9011-02-3 | 10 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Simvastatin |
Extract from the above information
More
Extract from the above information |
79902-63-9 | 63 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Isatidis Radix |
|
0 |